Works by Jauw, Yvonne W. S.

Results: 14

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Published in:
2018
By:
- Jauw, Yvonne W. S.;
- Heijtel, Dennis F.;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- de Vet, Henrica C. W.;
- Vugts, Danielle J.;
- Verheul, Henk M.;
- Boellaard, Ronald;
- Zweegman, Sonja;
- van Dongen, Guus A. M. S.;
- der Houven van Oordt, C. Willemien Menke-van;
- Lammertsma, Adriaan A.;
- Huisman, Marc C.
Publication type:
journal article
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
By:
- Wijngaarden, Jessica E.;
- Huisman, Marc C.;
- Jauw, Yvonne W. S.;
- van Dongen, Guus A. M. S.;
- Greuter, Henri N. J. M.;
- Schuit, Robert C.;
- Cleveland, Matthew;
- Gootjes, Elske C.;
- Vugts, Daniëlle J.;
- Menke-van der Houven van Oordt, C. Willemien;
- Boellaard, Ronald
Publication type:
Article
Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
By:
- Jauw, Yvonne W. S.;
- Bensch, Frederike;
- Brouwers, Adrienne H.;
- Hoekstra, Otto S.;
- Zijlstra, Josée M.;
- Pieplenbosch, Simone;
- Schröder, Carolien P.;
- Zweegman, Sonja;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, C. Willemien;
- de Vries, Elisabeth G. E.;
- de Vet, Henrica C. W.;
- Boellaard, Ronald;
- Huisman, Marc C.
Publication type:
Article
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40218-1
By:
- Ferrández, Maria C.;
- Golla, Sandeep S. V.;
- Eertink, Jakoba J.;
- de Vries, Bart M.;
- Lugtenburg, Pieternella J.;
- Wiegers, Sanne E.;
- Zwezerijnen, Gerben J. C.;
- Pieplenbosch, Simone;
- Kurch, Lars;
- Hüttmann, Andreas;
- Hanoun, Christine;
- Dührsen, Ulrich;
- de Vet, Henrica C. W.;
- PETRA;
- Hoekstra, Otto S.;
- Burggraaff, Coreline N.;
- Bes, Annelies;
- Heymans, Martijn W.;
- Jauw, Yvonne W. S.;
- Chamuleau, Martine E. D.
Publication type:
Article
Feasibility of Using 18 F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung Disease.
Published in:
Diagnostics (2075-4418), 2024, v. 14, n. 22, p. 2531, doi. 10.3390/diagnostics14222531
By:
- Smith, Charlotte L. C.;
- Zwezerijnen, Gerben J. C.;
- Wiegers, Sanne E.;
- Jauw, Yvonne W. S.;
- Lugtenburg, Pieternella J.;
- Zijlstra, Josée M.;
- Yaqub, Maqsood;
- Boellaard, Ronald
Publication type:
Article
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.
Published in:
Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596
By:
- de Vries, Bart M.;
- Golla, Sandeep S. V.;
- Zwezerijnen, Gerben J. C.;
- Hoekstra, Otto S.;
- Jauw, Yvonne W. S.;
- Huisman, Marc C.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, Willemien C.;
- Zijlstra-Baalbergen, Josée J. M.;
- Mesotten, Liesbet;
- Boellaard, Ronald;
- Yaqub, Maqsood
Publication type:
Article
89Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
By:
- Jauw, Yvonne W. S.;
- O’Donoghue, Joseph A.;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- Willemien Menke-van der Houven van Oordt, C.;
- Morschhauser, Franck;
- Carrasquillo, Jorge A.;
- Zweegman, Sonja;
- Taskar, Neeta Pandit-;
- Lammertsma, Adriaan A.;
- van Dongen, Guus. A. M. S.;
- Boellaard, Ronald;
- Weber, Wolfgang A.;
- Huisman, Marc C.
Publication type:
Article
Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.
Published in:
EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8
By:
- Jauw, Yvonne W. S.;
- Huisman, Marc C.;
- Nayak, Tapan K.;
- Vugts, Danielle J.;
- Christen, Randolph;
- Naegelen, Valerie Meresse;
- Ruettinger, Dominik;
- Heil, Florian;
- Lammertsma, Adriaan A.;
- Verheul, Henk M. W.;
- Hoekstra, Otto S.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, C. Willemien
Publication type:
Article
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study.
Published in:
EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00927-6
By:
- Wijngaarden, Jessica E.;
- Huisman, Marc C.;
- Pouw, Johanna E. E.;
- Menke-van der Houven van Oordt, C. Willemien;
- Jauw, Yvonne W. S.;
- Boellaard, Ronald
Publication type:
Article
Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example.
Published in:
EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00813-7
By:
- Huisman, Marc C.;
- Menke-van der Houven van Oordt, C. Willemien;
- Zijlstra, Josée M.;
- Hoekstra, Otto S.;
- Boellaard, Ronald;
- van Dongen, Guus A. M. S.;
- Shah, Dhaval K.;
- Jauw, Yvonne W. S.
Publication type:
Article
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Published in:
PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169828
By:
- Jauw, Yvonne W. S.;
- Zijlstra, Josée M.;
- de Jong, Daphne;
- Vugts, Danielle J.;
- Zweegman, Sonja;
- Hoekstra, Otto S.;
- van Dongen, Guus A. M. S.;
- Huisman, Marc C.
Publication type:
Article
Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images.
Published in:
EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00444-4
By:
- Somasundaram, Ananthi;
- García, David Vállez;
- Pfaehler, Elisabeth;
- Jauw, Yvonne W. S.;
- Zijlstra, Josée M.;
- van Dongen, Guus A. M. S.;
- Menke-van der Houven van Oordt, Willemien C.;
- Huisman, Marc C.;
- de Vries, Elisabeth G. E.;
- Boellaard, Ronald
Publication type:
Article
Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET.
Published in:
EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
By:
- Wijngaarden, Jessica E.;
- Jauw, Yvonne W. S.;
- Zwezerijnen, Gerben J. C.;
- de Wit-van der Veen, Berlinda J.;
- Vugts, Daniëlle J.;
- Zijlstra, Josée M.;
- van Dongen, Guus A. M. S.;
- Boellaard, Ronald;
- Menke-van der Houven van Oordt, C. Willemien;
- Huisman, Marc C.
Publication type:
Article
Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients.
Published in:
Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1828, doi. 10.2967/jnumed.109.065862
By:
- Börjesson, Pontus K. E.;
- Jauw, Yvonne W. S.;
- de Bree, Remco;
- Roos, Jan C.;
- Castelijns, Jonas A.;
- Leemans, C. Réne;
- van Dongen, Guus A. M. S.;
- Boellaard, Ronald
Publication type:
Article

Works by Jauw, Yvonne W. S.

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.

Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.

Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.

Feasibility of Using 18 F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung Disease.

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.

<sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Optimal imaging time points considering accuracy and precision of Patlak linearization for <sup>89</sup>Zr-immuno-PET: a simulation study.

Potential and pitfalls of <sup>89</sup>Zr-immuno-PET to assess target status: <sup>89</sup>Zr-trastuzumab as an example.

Performance of <sup>89</sup>Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Noise sensitivity of <sup>89</sup>Zr-Immuno-PET radiomics based on count-reduced clinical images.

Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

Radiation Dosimetry of <sup>89</sup>Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients.